KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition.
Rouleau
E
E
Spyratos
F
F
Dieumegard
B
B
Guinebretière
J M
JM
Lidereau
R
R
Bièche
I
I
D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000235:genetics* / Q000628:therapy; D066246:ErbB Receptors / Q000378:metabolism*; D006801:Humans; D009154:Mutation / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins / Q000235:genetics* / Q000378:metabolism
C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D066246:ErbB Receptors; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins